Jasdip Kaur

Jasdip Kaur practices at Manshadi Heart Institute Inc in Lodi, California.

Jasdip Kaur's NPI, 1619548591, was assigned on July 1, 2021. Jasdip Kaur holds California license 95017293.

Jasdip Kaur's primary practice is Manshadi Heart Institute Inc, at 1210 W Tokay St, Lodi, CA 95240 in San Joaquin County. The practice phone is (209) 944-5530.

Jasdip Kaur's primary practice is Manshadi Heart Institute Inc in Lodi, California. Jasdip Kaur is also affiliated with Sutter Tracy Community Hospital. The medical group on file is SGMF Radiology. Dmand AI also links Jasdip Kaur to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jasdip Kaur practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Jasdip Kaur's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Jasdip Kaur is licensed in California.

Dmand AI lists chronic diabetes, high cholesterol, muscle pain, fibromyalgia, and limb pain and tobacco use among the conditions Jasdip Kaur treats.

CMS data shows 646 Medicare services from Jasdip Kaur across 3 procedure codes in 2024, for 342 Medicare patients. Medicare paid $40,731 for them. Every service was in an office.

CMS counts 342 Medicare patients who saw Jasdip Kaur in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 69% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jasdip Kaur's median patient age at 62, with 56% women.

In 2024, Jasdip Kaur wrote 1,380 Medicare Part D claims for 270 patients. 79% of them were for generic drugs. CMS names the drug for 1,282 of them, across 26 drugs with 11 or more claims each, at $197,700 in total drug cost.

Jasdip Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jasdip Kaur as offering telehealth.

CMS Open Payments shows 5 general payments to Jasdip Kaur from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $41.